Patient Capital Management’s Ovintiv OVV Stock Holding History

Patient Capital Management’s Portfolio OVV Stock Details OVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-730,990	Closed	-$34.8M	–	45
2023 Q3	$34.8M	Sell	730,990 -566,104	-44%	-$25.6M	2.04%	24
2023 Q2	$49.4M	Buy	1,297,094 +1,068,794	+468%	+$38.6M	2.75%	18
2023 Q1	$8.24M	Sell	228,300 -22,100	-9%	-$975K	3.67%	7
2022 Q4	$12.7M	Sell	250,400 -7,500	-3%	-$392K	6.16%	1
2022 Q3	$11.9M	Sell	257,900 -4,100	-2%	-$196K	5.92%	1
2022 Q2	$11.6M	Sell	262,000 -4,200	-2%	-$216K	5.13%	3
2022 Q1	$14.4M	Sell	266,200 -4,375	-2%	-$189K	4.88%	2
2021 Q4	$9.12M	Buy	+270,575	New	+$9.66M	2.63%	10

Other funds holding OVV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Smead Capital Management Phoenix, Arizona $4.6B AUM 27.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EECFX

EnCap Energy Capital Fund XI Houston, Texas $1.14B AUM 5.31% 1-Year Est. Return

Patient Capital Management's OVV Position: Q4 2023 in Review

Patient Capital Management sold out of Ovintiv (OVV) in Q4 2023, closing a stake of 730,990 shares — an estimated $34.8M sold.

Patient Capital Management first reported a position in OVV in Q4 2021 and held it in 8 quarters. The position peaked at $49.4M in Q2 2023. 499 funds tracked by Wall St. Rank hold OVV as of Q4 2023.

Patient Capital Management reported no remaining Ovintiv position as of Q4 2023 after selling out during the quarter.
Patient Capital Management sold 730,990 Ovintiv shares in Q4 2023, an estimated $34.8M.
Patient Capital Management first reported a position in Ovintiv in Q4 2021 and held it in 8 quarters.
Patient Capital Management's Ovintiv position peaked at $49.4M in Q2 2023.
499 funds tracked by Wall St. Rank held Ovintiv as of Q4 2023.

Based on Patient Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.